Biomaterials:热降解水凝胶实现药物按需递送

2017-03-10佚名上海市调控生物学重点实验室

水凝胶材料近年来在生物医药领域受到了广泛关注,例如作为药物递送载体、组织再生支架、外科手术缝合胶等。负载药物的水凝胶可在体内保持数日乃至数周的持续释放,很大程度上提高了药物的利用度和病人的耐受性,并降低药物毒副作用。如在水凝胶材料中引入酸、酶、光、热等刺激响应元件,则可进一步赋予水凝胶药物载体更加灵活可变的药物控制释放性能。近日,华东师范大学的程义云教授团队研发出一种可在43摄氏度的条件下快速降解

水凝胶材料近年来在生物医药领域受到了广泛关注,例如作为药物递送载体、组织再生支架、外科手术缝合胶等。负载药物的水凝胶可在体内保持数日乃至数周的持续释放,很大程度上提高了药物的利用度和病人的耐受性,并降低药物毒副作用。如在水凝胶材料中引入酸、酶、光、热等刺激响应元件,则可进一步赋予水凝胶药物载体更加灵活可变的药物控制释放性能。近日,华东师范大学的程义云教授团队研发出一种可在43摄氏度的条件下快速降解的水凝胶,用于体内局部给药。这种水凝胶与光热材料结合,实现红外光(NIR)控制的药物按需递送。相关研究成果近期以A thermo-degradable hydrogel with light-tunable degradation and drug release为题发表在Biomaterials (2017, 112, 133-140)。


研究人员将偶氮类化合物改性成为两端为醛基的热降解交联剂(Thermo- degradable linker, TDL),与末端为氨基的四臂聚乙二醇交联形成水凝胶。该交联剂中的偶氮键可受热断裂,当温度上升到对应的化学键断裂温度时,凝胶的机械强度逐渐降低,呈现出热降解性能。其中由偶氮二异丁基咪唑啉改性得到的交联剂(TDL1)的热降解温度较低,大约在43摄氏度左右即可促发降解。在水凝胶中掺入光热纳米材料后,可通过近红外光来精确控制水凝胶中生物活性分子的释放。小鼠实验表明该水凝胶具有良好的生物相容性和体内稳定性,而近红外光的照射可促发水凝胶在体内快速降解,从而触发荧光探针、蛋白质、药物等分子的可控释放,有望实现药物的按需递送。该论文的第一作者为华东师范大学生命科学学院的胡婧婧博士。

原始出处:

Jingjing Hu, Yihua Chen, Yunqi Li,et alA thermo-degradable hydrogel with light-tunable degradation and drug releaseBiomaterials. 2017 Jan.

小M推荐:Cell:“水凝胶”态蛋白质帮助细胞响应刺激

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区(5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1199733, encodeId=f37d1199e33ba, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220305/2453c61b0aba4c3ba23fcf2f183232cd/2d509a40bbce410192ebbbb7a44dce3b.jpg, createdBy=0b686537160, createdName=交叉学科小博士, createdTime=Sat Mar 05 20:37:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917387, encodeId=65f2191e38715, content=#Bio#, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jan 18 10:33:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049977, encodeId=8cd720499e7ee, content=#Biomaterials#, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3451, encryptionId=cbdd3451e3, topicName=Biomaterials)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e0333, createdName=zhangyxzsh, createdTime=Wed Apr 12 16:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307992, encodeId=eeb7130e9921e, content=#水凝胶#, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64149, encryptionId=edd364149bc, topicName=水凝胶)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Sun Mar 12 13:33:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460922, encodeId=d9f314609229f, content=#凝胶#, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Sun Mar 12 13:33:00 CST 2017, time=2017-03-12, status=1, ipAttribution=)]
    2022-03-05 交叉学科小博士

    受益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1199733, encodeId=f37d1199e33ba, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220305/2453c61b0aba4c3ba23fcf2f183232cd/2d509a40bbce410192ebbbb7a44dce3b.jpg, createdBy=0b686537160, createdName=交叉学科小博士, createdTime=Sat Mar 05 20:37:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917387, encodeId=65f2191e38715, content=#Bio#, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jan 18 10:33:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049977, encodeId=8cd720499e7ee, content=#Biomaterials#, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3451, encryptionId=cbdd3451e3, topicName=Biomaterials)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e0333, createdName=zhangyxzsh, createdTime=Wed Apr 12 16:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307992, encodeId=eeb7130e9921e, content=#水凝胶#, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64149, encryptionId=edd364149bc, topicName=水凝胶)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Sun Mar 12 13:33:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460922, encodeId=d9f314609229f, content=#凝胶#, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Sun Mar 12 13:33:00 CST 2017, time=2017-03-12, status=1, ipAttribution=)]
    2018-01-18 sunylz
  3. [GetPortalCommentsPageByObjectIdResponse(id=1199733, encodeId=f37d1199e33ba, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220305/2453c61b0aba4c3ba23fcf2f183232cd/2d509a40bbce410192ebbbb7a44dce3b.jpg, createdBy=0b686537160, createdName=交叉学科小博士, createdTime=Sat Mar 05 20:37:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917387, encodeId=65f2191e38715, content=#Bio#, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jan 18 10:33:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049977, encodeId=8cd720499e7ee, content=#Biomaterials#, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3451, encryptionId=cbdd3451e3, topicName=Biomaterials)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e0333, createdName=zhangyxzsh, createdTime=Wed Apr 12 16:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307992, encodeId=eeb7130e9921e, content=#水凝胶#, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64149, encryptionId=edd364149bc, topicName=水凝胶)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Sun Mar 12 13:33:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460922, encodeId=d9f314609229f, content=#凝胶#, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Sun Mar 12 13:33:00 CST 2017, time=2017-03-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1199733, encodeId=f37d1199e33ba, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220305/2453c61b0aba4c3ba23fcf2f183232cd/2d509a40bbce410192ebbbb7a44dce3b.jpg, createdBy=0b686537160, createdName=交叉学科小博士, createdTime=Sat Mar 05 20:37:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917387, encodeId=65f2191e38715, content=#Bio#, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jan 18 10:33:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049977, encodeId=8cd720499e7ee, content=#Biomaterials#, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3451, encryptionId=cbdd3451e3, topicName=Biomaterials)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e0333, createdName=zhangyxzsh, createdTime=Wed Apr 12 16:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307992, encodeId=eeb7130e9921e, content=#水凝胶#, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64149, encryptionId=edd364149bc, topicName=水凝胶)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Sun Mar 12 13:33:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460922, encodeId=d9f314609229f, content=#凝胶#, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Sun Mar 12 13:33:00 CST 2017, time=2017-03-12, status=1, ipAttribution=)]
    2017-03-12 tastas
  5. [GetPortalCommentsPageByObjectIdResponse(id=1199733, encodeId=f37d1199e33ba, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220305/2453c61b0aba4c3ba23fcf2f183232cd/2d509a40bbce410192ebbbb7a44dce3b.jpg, createdBy=0b686537160, createdName=交叉学科小博士, createdTime=Sat Mar 05 20:37:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917387, encodeId=65f2191e38715, content=#Bio#, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jan 18 10:33:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049977, encodeId=8cd720499e7ee, content=#Biomaterials#, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3451, encryptionId=cbdd3451e3, topicName=Biomaterials)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e0333, createdName=zhangyxzsh, createdTime=Wed Apr 12 16:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307992, encodeId=eeb7130e9921e, content=#水凝胶#, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64149, encryptionId=edd364149bc, topicName=水凝胶)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Sun Mar 12 13:33:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460922, encodeId=d9f314609229f, content=#凝胶#, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31310, encryptionId=de4331310a4, topicName=凝胶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09e6383467, createdName=lishizhe, createdTime=Sun Mar 12 13:33:00 CST 2017, time=2017-03-12, status=1, ipAttribution=)]
    2017-03-12 lishizhe

相关威廉亚洲官网

J Control Release:甜玉米使得动物疫苗变得更安全

普渡大学研究人员正在进行一项研究,从甜玉米中提取某种生物材料可使动物疫苗变得更加安全,动物疫苗制造商可因此而获益,该研究结果发表于《控释杂志》。Harm HogenEsch教授和Yuan Yao教授正尝试从非转基因甜玉米中提取某种生物材料作为动物疫苗中的一种佐剂使用。这种佐剂可刺激机体产生免疫反应,提高疫苗的性能。通常疫苗中所用的佐剂,如油乳剂和铝,都存在一些缺点。“常规使用的油乳剂和铝是不可降解

免疫系统与生物材料:不是敌人而是盟友

各种各样的生物材料经常被植入人体以治疗疾病或者修复机体损伤。在设计和加工这些生物材料时,一个主要的原则是设法降低这些材料在植入体内后对免疫系统的刺激,然而一项新的研究却表明:适当的免疫系统反应反而有助于生物材料更好地发挥作用。 来自美国约翰·霍普金斯大学的研究人员首先在普通的实验用小鼠身上制造肌肉损伤,然后分别将几种生物材料植入受伤部位。观察表明,植入的生物材料显著地刺激了受伤部位周围的免

PNAS:科学家发明可完全降解的生物材料以促进骨修复

Tufts大学工程学院的生物医学工程师最近发现了第一种可完全降解的全聚合骨支架材料,并且证实了这种材料在骨修复中可以提供足够的力学支撑。这项新技术使用了微米级的丝纤维用以加强材料的强度,类似于钢筋的作用原理。它可以促进由于创伤或者其他疾病引起的骨及其他组织的修复。 在美国,大约130万人每年要接受骨移植物的手术治疗。人类骨坚硬但是相对轻薄,可以承受相当程度的压力以及具有一定的韧性可以承受一定

NRR:长段周围神经损伤修复的生物材料

  对于周围神经,现在应用比较普遍的是自体或同种异体神经移植,后者与异种异体移植一样存在免疫排斥的问题。应用神经导管修复周围神经缺损的研究主要集中在小于30mm缺损的修复。伊朗伊斯兰阿扎德大学的Esmaeil Biazar博士所在研究组研究了纳米纤维聚羟基丁酸戊酸共聚酯(PHBV)神经导管修复大于30mm长段坐骨神经的缺损。4个月后,大体观察和组织学评估发现纳米纤维导管内的坐骨神